Table 2.

Eczema characteristics of the three clinical groups.

	Control		All Eczema (Non Allergen Sensitized Atopic Eczema & Allergen Sensitized Atopic Eczema)		Non Allergen Sensitized Atopic Eczema (NAE)		Allergen Sensitized Atopic Eczema (AE)
	N = 30		N = 33		N = 14		N = 19
	n	%	n	%	n	%	n	%
Age of onset of eczema
Before 3rd month			12	(40.00)	3	(27.27)	9	(47.37)
Between 3rd and 6th month			11	(36.67)	3	(27.27)	8	(42.11)
Between 6th and 12th month			4	(13.33)	3	(27.27)	1	(5.26)
Between 12th and 18th month			3	(10.00)	2	(18.18)	1	(5.26)
Mean ± SD (Range)			4.7 ± 4.6 (1.0–18.0)		6.4 ± 5.6 (1.5–18.0)		3.7 ± 3.7 (1.0–18.0)
SCORAD Index Score†
At 18 Months – Mean ± SD (Range)			19.7 ± 11.0 (7.1–46.1)		15.6 ± 5.0 (10.7–20.3)		23.7 ± 14.0 (7.1–46.1)
At 36 Months – Mean ± SD (Range)			25.0 ± 17.8 (7.1–69.4)		17.2 ± 6.9 (7.1–22.7)		30.1 ± 21.5 (12.8–69.4)
Other allergic co-morbiditides
Wheezing	0	(0.00)	6	(18.75)*	2	(14.29)	4	(22.22)*
Rhinitis	3	(10.00)	20	(60.61)*	9	(64.29)*	11	(57.89)*
Food allergy	0	(0.00)	6	(18.75)*	0	(0.00)	6	(33.33)*

†SCORing of Atopic Dermatitis severity assessments (SCORAD) were performed by trained physicians at 18 and 36 months for evaluation of eczema severity.

*Significant at P < .05 compared with the healthy group in univariate analysis.